A detailed history of Copperwynd Financial, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Copperwynd Financial, LLC holds 10,248 shares of NVO stock, worth $710,391. This represents 0.2% of its overall portfolio holdings.

Number of Shares
10,248
Previous 8,068 27.02%
Holding current value
$710,391
Previous $694,000 2.45%
% of portfolio
0.2%
Previous 0.19%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 05, 2025

BUY
$69.3 - $90.95 $151,074 - $198,271
2,180 Added 27.02%
10,248 $711,000
Q4 2024

Feb 10, 2025

BUY
$85.0 - $120.04 $55,250 - $78,026
650 Added 8.76%
8,068 $694,000
Q3 2024

Nov 04, 2024

BUY
$119.07 - $145.42 $84,658 - $103,393
711 Added 10.6%
7,418 $883,000
Q2 2024

Aug 15, 2024

BUY
$122.71 - $146.91 $122,464 - $146,616
998 Added 17.48%
6,707 $957,000
Q1 2024

Apr 30, 2024

BUY
$102.11 - $135.92 $77,909 - $103,706
763 Added 15.43%
5,709 $733,000
Q4 2023

Feb 13, 2024

BUY
$87.78 - $105.45 $434,159 - $521,555
4,946 New
4,946 $511,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $156B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Copperwynd Financial, LLC Portfolio

Follow Copperwynd Financial, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Copperwynd Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Copperwynd Financial, LLC with notifications on news.